BR0007472A - Agente contendo paramilonas, seco por congelação, sua produção e utilização - Google Patents

Agente contendo paramilonas, seco por congelação, sua produção e utilização

Info

Publication number
BR0007472A
BR0007472A BR0007472-1A BR0007472A BR0007472A BR 0007472 A BR0007472 A BR 0007472A BR 0007472 A BR0007472 A BR 0007472A BR 0007472 A BR0007472 A BR 0007472A
Authority
BR
Brazil
Prior art keywords
production
freeze
agent containing
paramilones
dried agent
Prior art date
Application number
BR0007472-1A
Other languages
English (en)
Inventor
Wolfgang Suwelack
Petra Tewes-Schwarzer
Dietrich Baeumer
Uwe Kahmann
Original Assignee
Suwelack Skin & Health Care Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suwelack Skin & Health Care Ag filed Critical Suwelack Skin & Health Care Ag
Publication of BR0007472A publication Critical patent/BR0007472A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Abstract

Patente de Invenção:<B>''AGENTE CONTENDO PARAMILONAS, SECO POR CONGELAçãO, SUA PRODUçãO E UTILIZAçãO''<D>. A invenção refere-se a um agente, caracterizado pelo fato de que ele contém 0,1 a 100% em peso de paramilona seca por congelação, à produção e utilização do mesmo.
BR0007472-1A 1999-02-10 2000-02-08 Agente contendo paramilonas, seco por congelação, sua produção e utilização BR0007472A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99102499A EP1029892B1 (de) 1999-02-10 1999-02-10 Beta-1,3-Glucan aus Euglena enthaltendes gefriergetrocknetes Erzeugnis, seine Herstellung und Verwendung
PCT/EP2000/000986 WO2000047668A1 (de) 1999-02-10 2000-02-08 Paramylonenthaltendes gefriergetrocknetes mittel, seine herstellung und verwendung

Publications (1)

Publication Number Publication Date
BR0007472A true BR0007472A (pt) 2001-10-16

Family

ID=8237533

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0007472-1A BR0007472A (pt) 1999-02-10 2000-02-08 Agente contendo paramilonas, seco por congelação, sua produção e utilização

Country Status (19)

Country Link
US (1) US20030203016A1 (pt)
EP (2) EP1029892B1 (pt)
JP (1) JP2003529538A (pt)
KR (1) KR20010102053A (pt)
CN (1) CN1340079A (pt)
AU (1) AU769168B2 (pt)
BR (1) BR0007472A (pt)
CA (1) CA2359706A1 (pt)
CZ (1) CZ20012783A3 (pt)
DE (1) DE59901613D1 (pt)
ES (1) ES2175863T3 (pt)
HK (1) HK1042507A1 (pt)
HU (1) HUP0200385A2 (pt)
MX (1) MXPA01007710A (pt)
NO (1) NO20013883L (pt)
PL (1) PL350852A1 (pt)
SK (1) SK11192001A3 (pt)
TR (1) TR200102342T2 (pt)
WO (1) WO2000047668A1 (pt)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ518739A (en) * 1999-11-02 2004-12-24 Depomed Inc Pharmacological inducement of the fed mode for enhanced drug administration to the stomach
DE10010113B4 (de) * 2000-03-03 2009-05-07 Wolfgang Dr. Schatton Natives Schwammkollagen, Verfahren zu seiner Isolierung und seine Verwendung, sowie natives nanopartikuläres Schwammkollagen, Verfahren zu seiner Herstellung und seine Verwendung
DE10017530A1 (de) * 2000-04-10 2001-10-18 Suwelack Skin & Health Care Ag Maske aus flexiblen, zur Flüssigkeitsaufnahme geeigneten Träger, Pflegeset enthaltend diese Maske, Verfahren zur Herstellung einer Maske sowie Verfahren zur kosmetischen Behandlung unter Verwendung dieser Maske
DE10117751A1 (de) * 2001-04-09 2002-11-21 Siemens Ag Modellierung von Momentanzuständen medizinischer Objekte in Abhängigkeit von zumindest einer Messgröße
MXPA04002980A (es) 2001-09-28 2005-06-20 Johnson & Johnson Formas de dosificacion que tienen un nucleo interior y coraza exterior con diferentes formas.
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
DE50214914D1 (de) * 2001-12-06 2011-03-31 Schuette Reichel Gbr Mittel zur behandlung von übergewicht in kombination mit weiteren indikationen
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US20040213838A1 (en) * 2003-04-24 2004-10-28 Mazer Terrence B. Medical food tablets containing free amino acids
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US7558414B2 (en) * 2006-09-11 2009-07-07 Case Western Reserve University Iterative image reconstruction
JP4865838B2 (ja) * 2009-05-29 2012-02-01 株式会社ユーグレナ プリン体吸収抑制組成物
JP5612875B2 (ja) * 2010-03-09 2014-10-22 株式会社ユーグレナ １型又は４型過敏症のアレルギー症状抑制剤又は１型過敏症のアレルギー症状抑制剤
JP5882675B2 (ja) * 2011-10-26 2016-03-09 株式会社Kri パラミロン粒子を含有する複合体
US10265340B2 (en) 2012-02-22 2019-04-23 Kemin Industries, Inc. Animal feed compositions and methods of using the same
US9574217B2 (en) 2012-05-07 2017-02-21 Algal Scientific Corporation Multi-stage process for production of immune modulator
US10130099B2 (en) 2013-03-14 2018-11-20 Kemin Industries, Inc. Modulation of plant immune system function
JP6139259B2 (ja) * 2013-05-02 2017-05-31 株式会社ユーグレナ 創傷治療剤の製造方法
CN105431534B (zh) 2013-08-02 2017-10-24 优瑞纳股份有限公司 内切－1，3－β－葡聚糖酶、多核苷酸、重组载体、转化体、内切－1，3－β－葡聚糖酶的制造方法、酶制剂及低分子化裸藻淀粉的制造方法
JP2015214623A (ja) * 2014-05-08 2015-12-03 株式会社神鋼環境ソリューション 微細藻類からβ−グルカンを分離する分離方法
JP5931146B2 (ja) * 2014-09-05 2016-06-08 株式会社ユーグレナ １型又は４型過敏症のアレルギー症状抑制剤
CN107073032B (zh) 2014-09-29 2020-12-22 悠绿那股份有限公司 肾衰竭发展抑制剂、肾衰竭预防剂及硫酸吲哚酚产生抑制剂
JP6148218B2 (ja) * 2014-09-29 2017-06-14 株式会社ユーグレナ 腎不全進行抑制剤、腎不全予防剤、尿毒症治療剤、インドキシル硫酸産生阻害剤、心血管系疾患予防剤、及び食品組成物
JP5899350B1 (ja) * 2015-03-25 2016-04-06 株式会社神鋼環境ソリューション パラミロン製造方法
JP5899349B1 (ja) * 2015-03-25 2016-04-06 株式会社神鋼環境ソリューション パラミロン製造方法
JP6190844B2 (ja) * 2015-04-08 2017-08-30 株式会社ユーグレナ 膨潤パラミロン及びその製造方法
JP6604590B2 (ja) * 2015-08-13 2019-11-13 株式会社ユーグレナ ユーグレナ及びその培養方法並びにパラミロン及びその製造方法
WO2017149858A1 (ja) * 2016-03-04 2017-09-08 株式会社ユーグレナ 抗ウイルス剤及び抗ウイルス用食品
CN107233217A (zh) * 2016-03-25 2017-10-10 李和伟 一种含有表面活性剂的冻干制剂及其洗护产品
CN105942310A (zh) * 2016-04-28 2016-09-21 北京珍生康业生物科技有限公司 一种破膜裸藻干粉的制备方法
EP3469089A4 (en) * 2016-06-09 2019-05-08 F3 Platform Biologics, Inc. EUGLENA LYSATE COMPOSITION AND METHOD FOR PREPARING THE COMPOSITION AND PURIFIED BETA-1,3-GLUCAN
US20180169161A1 (en) * 2016-06-09 2018-06-21 Algaeon, Inc. Euglena derived composition having immune response inducing components
US9901606B2 (en) 2016-06-09 2018-02-27 Algaeon, Inc. Euglena lysate composition
JP7001436B2 (ja) * 2017-11-16 2022-01-19 株式会社神鋼環境ソリューション 添加剤、及び、該添加剤を含む組成物
AU2020231101A1 (en) * 2019-03-01 2021-09-09 Noblegen Inc. Compositions, preparation and uses of paramylon
KR102083165B1 (ko) * 2019-09-18 2020-03-02 대상 주식회사 베타-1,3-글루칸 생산능을 갖는 신규의 유글레나 속 균주 및 이를 이용한 베타-1,3-글루칸을 함유하는 유글레나 균체의 제조방법
CN110623792B (zh) * 2019-09-23 2022-05-06 温州医科大学附属第一医院 一种医学敷料及其制备方法
CN112852905B (zh) * 2021-02-05 2023-06-23 优格天成生物技术(义乌)有限公司 二肽在提高裸藻中副淀粉含量中的应用
WO2022195566A1 (en) * 2021-03-19 2022-09-22 Noblegen Inc. Dairy and meat analogues containing euglena-derived components
CN115721771B (zh) * 2022-10-22 2024-02-02 湖南中腾湘岳生物科技有限公司 一种医用海绵、制备方法及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4774093A (en) * 1985-06-25 1988-09-27 Fmc Corporation Polysaccharide compositions, preparation and uses
JPH03167102A (ja) * 1989-11-24 1991-07-19 Harima Chem Inc 抗菌剤
DE4328329C2 (de) * 1992-08-26 1998-02-12 Suwelack Nachf Dr Otto Gefriergetrocknete Biomatrix
GB2310668B (en) * 1996-02-28 2000-04-19 Johnson & Johnson Medical Solid polysaccharide materials for use as wound dressings
AU7908798A (en) * 1997-07-02 1999-01-25 Coloplast A/S A method for preparing a non-fibrous porous material
DE29723220U1 (de) * 1997-09-05 1998-05-28 Suwelack Nachf Dr Otto Mittel zur peroralen Verabreichung

Also Published As

Publication number Publication date
CZ20012783A3 (cs) 2002-03-13
SK11192001A3 (sk) 2002-03-05
EP1196495A1 (de) 2002-04-17
MXPA01007710A (es) 2003-06-24
WO2000047668A1 (de) 2000-08-17
US20030203016A1 (en) 2003-10-30
NO20013883L (no) 2001-10-09
PL350852A1 (en) 2003-02-10
DE59901613D1 (de) 2002-07-11
EP1029892A1 (de) 2000-08-23
EP1029892B1 (de) 2002-06-05
CA2359706A1 (en) 2000-08-17
AU2802800A (en) 2000-08-29
HUP0200385A2 (en) 2002-05-29
NO20013883D0 (no) 2001-08-09
CN1340079A (zh) 2002-03-13
JP2003529538A (ja) 2003-10-07
TR200102342T2 (tr) 2002-01-21
KR20010102053A (ko) 2001-11-15
HK1042507A1 (zh) 2002-08-16
AU769168B2 (en) 2004-01-15
ES2175863T3 (es) 2002-11-16

Similar Documents

Publication Publication Date Title
BR0007472A (pt) Agente contendo paramilonas, seco por congelação, sua produção e utilização
BR9916132A (pt) Composições e utilização das mesmas
PT1109812E (pt) Pirrolobenzodiazepinas
BR9807742A (pt) EpotilÈneos que são modificados na cadeia lateral
ES2195970T3 (es) L-ribavirina y usos de la misma.
CY1111119T1 (el) Φαρμακευτικα σκευασματα που περιλαμβανουν κολλοειδες διοξειδιο του πυριτιου
HN1999000154A (es) 1,2,3,4 tetrahidroquinolinas 2 sustituidas 4 - carboxiamino sustituidas.
BR9907249A (pt) Conector de válvula de borboleta
TR200003036T2 (tr) 12,13-Modifiye edilmiş epotilon türevleri
BR9910180A (pt) Composição farmacêutica, processos para o tratamento de uma condição associada com a transmissão reduzida de nicotina, para identificação de um modulador positivo de um agonista receptor nicotìnico e para identificação de um composto, composto, e, uso de um modulador positivo de um agonista receptor nicotìnico
BR0009480A (pt) Soluções de poliuretano com unidades de estrutura de alcoxissilano
PT1112266E (pt) 4-amino-2-aril-pirimidinas substituidas, sua preparacao, sua utilizacao e composicoes farmaceuticas que as contem.
RS50071B (sr) Novi oblik soli pantoprazola
GT200000143A (es) Empleo de formulaciones que contienen polisiloxano y agente deslizante de cadenas.
BR0308014A (pt) Composição translúcida ou transparente
BR9808140A (pt) Formulação unitária
IS6654A (is) Stöðugt gabapentín með pH innan stýrðra marka
BR9913865A (pt) Processo para revestir uma superfìcie com um agente de separação
DK0842165T3 (da) Thiazolidin-4-carboxylsyrederivater som cytobeskyttende midler
HN2002000235A (es) Formulaciones en combinacion de derivados de 1, 4 - benzotiepina - 1, 1 - dioxido con otras sustancias activas, y su utilización
PT1049706E (pt) Novos penta-sacaridos os respectivos metodos de producao e as composicoes farmaceuticas que os contem
BR0214399A (pt) Amplificador de trancamento
AR013411A1 (es) Composicion de aplicacion para tratamientos antivirales y afecciones micosicas y/o bacterianas y utilizacion de dichas composiciones.
BR0011261A (pt) Composição oral compreendendo perlita, e, uso de perlita
BR0112537A (pt) Preparações cosméticas de embelezamento contendo dialquilcarbonatos e óxidos de metal

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1925 DE 27/11/2007.